Article info

PDF
What if Prometheus had steatosis? Potential use of FGF19 to promote regeneration of the fatty liver

Authors

  • Philip M Brown Liver & Energy Metabolism Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Yaron Rotman Liver & Energy Metabolism Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yaron Rotman, Liver & Energy Metabolism Unit, Liver Diseases Branch, NIDDK, NIH, 10 Center Drive, Building 10, Room 10N248C, MSC1800, Bethesda, MD 20892-1800, USA; rotmany{at}niddk.nih.gov
View Full Text

Citation

Brown PM, Rotman Y
What if Prometheus had steatosis? Potential use of FGF19 to promote regeneration of the fatty liver

Publication history

  • Received February 14, 2017
  • Accepted February 16, 2017
  • First published March 8, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.